Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia
Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia
About this item
Full title
Author / Creator
Guilhot, François , Guilhot, Joëlle , Chastang, Claude , Michallet, Mauricette , Guerci, Agnès , Harousseau, Jean-Luc , Maloisel, Frédéric , Bouabdallah, Réda , Guyotat, Denis , Cheron, Nathalie , Nicolini, Franck , Abgrall, Jean-François , Tanzer, Joseph , Navarro, Maurice , Bordessoule, Dominique , Morice, Patrick , Ifrah, Norbert , Rochant, Henri , Vilque, Jean-Pierre , Delain, Martine and Bauters, Francis
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Chronic myelogenous leukemia has a poor outcome when treated with hydroxyurea or busulfan. These agents can control the disease, but they do not eliminate Philadelphia chromosome–positive stem cells from the bone marrow. Allogeneic bone marrow transplantation, considered to be the only curative treatment, prolongs survival in up to 70 percent of a...
Alternative Titles
Full title
Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia
Authors, Artists and Contributors
Author / Creator
Guilhot, Joëlle
Chastang, Claude
Michallet, Mauricette
Guerci, Agnès
Harousseau, Jean-Luc
Maloisel, Frédéric
Bouabdallah, Réda
Guyotat, Denis
Cheron, Nathalie
Nicolini, Franck
Abgrall, Jean-François
Tanzer, Joseph
Navarro, Maurice
Bordessoule, Dominique
Morice, Patrick
Ifrah, Norbert
Rochant, Henri
Vilque, Jean-Pierre
Delain, Martine
Bauters, Francis
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_223956449
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223956449
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJM199707243370402
